Update on the management of systemic lupus erythematosus from a pediatric nephrology perspective

Keith K. Lau, Lavjay Butani

Research output: Contribution to journalArticle

Abstract

Although systemic lupus erythematosus (SLE) has a peak incidence in young women, the disease often first presents during childhood. Moreover studies have suggested that patients with disease onset in childhood have a worse prognosis. Considering that renal involvement in SLE is the major determinant of long-term survival and morbidity, the focus of this article will be to review new and exciting approaches in the treatment of pediatric lupus nephritis by referencing the major studies over the last few years. Since membranous lupus nephritis is very different from other forms of lupus nephritis, the treatment of this specific form of renal involvement will not be discussed in great detail. Very few robust clinical trials have investigated the treatment of SLE and lupus nephritis in the pediatric population; hence most recommendations are based on adult clinical trials.

Original languageEnglish (US)
Pages (from-to)30-38
Number of pages9
JournalCurrent Rheumatology Reviews
Volume8
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Lupus Nephritis
Nephrology
Systemic Lupus Erythematosus
Pediatrics
Clinical Trials
Kidney
Therapeutics
Morbidity
Survival
Incidence
Population

Keywords

  • Lupus nephritis
  • Outcomes
  • Pediatrics
  • SLE

ASJC Scopus subject areas

  • Rheumatology

Cite this

Update on the management of systemic lupus erythematosus from a pediatric nephrology perspective. / Lau, Keith K.; Butani, Lavjay.

In: Current Rheumatology Reviews, Vol. 8, No. 1, 2012, p. 30-38.

Research output: Contribution to journalArticle

@article{b725fd94da154f9c80b073daa4870b9c,
title = "Update on the management of systemic lupus erythematosus from a pediatric nephrology perspective",
abstract = "Although systemic lupus erythematosus (SLE) has a peak incidence in young women, the disease often first presents during childhood. Moreover studies have suggested that patients with disease onset in childhood have a worse prognosis. Considering that renal involvement in SLE is the major determinant of long-term survival and morbidity, the focus of this article will be to review new and exciting approaches in the treatment of pediatric lupus nephritis by referencing the major studies over the last few years. Since membranous lupus nephritis is very different from other forms of lupus nephritis, the treatment of this specific form of renal involvement will not be discussed in great detail. Very few robust clinical trials have investigated the treatment of SLE and lupus nephritis in the pediatric population; hence most recommendations are based on adult clinical trials.",
keywords = "Lupus nephritis, Outcomes, Pediatrics, SLE",
author = "Lau, {Keith K.} and Lavjay Butani",
year = "2012",
doi = "10.2174/157339712801318984",
language = "English (US)",
volume = "8",
pages = "30--38",
journal = "Current Rheumatology Reviews",
issn = "1573-3971",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Update on the management of systemic lupus erythematosus from a pediatric nephrology perspective

AU - Lau, Keith K.

AU - Butani, Lavjay

PY - 2012

Y1 - 2012

N2 - Although systemic lupus erythematosus (SLE) has a peak incidence in young women, the disease often first presents during childhood. Moreover studies have suggested that patients with disease onset in childhood have a worse prognosis. Considering that renal involvement in SLE is the major determinant of long-term survival and morbidity, the focus of this article will be to review new and exciting approaches in the treatment of pediatric lupus nephritis by referencing the major studies over the last few years. Since membranous lupus nephritis is very different from other forms of lupus nephritis, the treatment of this specific form of renal involvement will not be discussed in great detail. Very few robust clinical trials have investigated the treatment of SLE and lupus nephritis in the pediatric population; hence most recommendations are based on adult clinical trials.

AB - Although systemic lupus erythematosus (SLE) has a peak incidence in young women, the disease often first presents during childhood. Moreover studies have suggested that patients with disease onset in childhood have a worse prognosis. Considering that renal involvement in SLE is the major determinant of long-term survival and morbidity, the focus of this article will be to review new and exciting approaches in the treatment of pediatric lupus nephritis by referencing the major studies over the last few years. Since membranous lupus nephritis is very different from other forms of lupus nephritis, the treatment of this specific form of renal involvement will not be discussed in great detail. Very few robust clinical trials have investigated the treatment of SLE and lupus nephritis in the pediatric population; hence most recommendations are based on adult clinical trials.

KW - Lupus nephritis

KW - Outcomes

KW - Pediatrics

KW - SLE

UR - http://www.scopus.com/inward/record.url?scp=84870163495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870163495&partnerID=8YFLogxK

U2 - 10.2174/157339712801318984

DO - 10.2174/157339712801318984

M3 - Article

AN - SCOPUS:84870163495

VL - 8

SP - 30

EP - 38

JO - Current Rheumatology Reviews

JF - Current Rheumatology Reviews

SN - 1573-3971

IS - 1

ER -